 |
市场调查报告书
商品编码
1907819
週边血管支架市场：市场规模、占有率、监管、报销、介入治疗及至2036年预测（按细分市场划分）Peripheral Vascular Stents Market Size by Segments, Share, Regulatory, Reimbursement, Interventions and Forecast to 2036 |
||||||
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
週边血管支架市场（规模、占有率、监管、报销、介入治疗及至2036年预测）旨在展现心血管器械治疗领域的定量和定性市场趋势。
週边血管支架是一种可扩张的带孔管，插入週边血管以防止血流受阻。由于人口老化、已开发国家疾病高发生率以及新型诊断方法的出现，微创治疗方法（如血管成形术和支架置入术）的应用日益增加。用于治疗週边动脉疾病 (PAD) 的微创技术包括球囊血管成形术、支架置放术和斑块切除术。这些治疗方法恢復时间短，感染和出血风险低，因此在临床实践中广泛应用。球囊血管成形术和支架植入术已取代侵入性动脉绕道手术，成为週边动脉疾病 (PAD) 患者的第一线治疗方案。这些微创手术用于疏通身体各部位（包括腿部、肾臟和颈动脉）的狭窄或阻塞动脉。週边支架植入术是将支架插入阻塞的周边动脉，扩张血管，恢復正常血流。由于球囊血管成形术有弹性回缩和新生内膜增生等问题，支架植入术已成为首选方案。
39 个国家的市场模型均采用颜色编码，并包含流行病学为基础的适应症和介入量，以及完整的资料来源说明。互动式 Excel 表格提供价值、数量、产品利用率、平均售价、市场规模和公司占有率分析（如有）。此外，分析师的评论和定性见解为定量数据提供了背景资讯。
市场模型的主要特征包括：
外周支架的当前市占率及不断变化的竞争格局
- 对关键产业趋势的深入分析
- 按细分市场划分的周边支架市场年度总收入及2015年至2036年的市场预测
- 按细分市场划分的总手术量、单位销售、平均售价和市场价值的详细数据
全球、区域和国家层面的市场洞察
- 除了定性的市场特定资讯外，我们还提供按区域划分的全球趋势细分分析。此外，GlobalData 分析师还提供针对特定国家市场的独特见解
- 外周支架市场的 SWOT 分析
- 外周支架市场的竞争格局及趋势
透过全面、整体的视角，加深您对市场的理解，包括医疗保健系统概览。此外， "市场准入" 部分透过报销政策和监管环境讯息，让您更深入地了解市场动态。
- 各国医疗保健系统概览。
- 各国报销政策。
- 各国医疗科技监管环境。
凭藉强大的研究方法和资料来源，该模型提供全面且准确的市场概览。主要需求和供应方资讯（包括关键产业专家）已整合到该联合模型中。此外，也利用真实世界资料来源来确定市场趋势。这些资料来源包括政府程式资料库、医院采购资料库和专有线上资料库。
涵盖的公司：W.L.戈尔公司 (Gore & Associates Inc.)、波士顿科学公司 (Boston Scientific Corp.)、巴德公司 (CR Bard Inc.)、威尔逊-库克医疗公司 (Wilson-Cook Medical Inc.)、雅培实验室 (Abbott Laboratories)、美敦力公司 (Medtronic Plc. (Biotronik SE & Co. KG)、京都医疗规划株式会社 (Kyoto Medical Planning Co. Ltd.) 等。
其他。
涵盖国家：美国、英国、德国、法国、义大利、西班牙、巴西、中国、印度、俄罗斯、日本、澳洲、加拿大、墨西哥、韩国、丹麦、爱尔兰、荷兰、纽西兰、南非、瑞典、瑞士、奥地利、比利时、芬兰、以色列、挪威、波兰、葡萄牙、台湾、捷克、希腊、匈牙利、土耳其、埃及、沙乌地阿拉伯、阿拉伯联合大公国、阿根廷和智利。
范围
此市场模型提供其他地方无法获得的关键专业知识。该模型揭示了特定市场内的定性和定量趋势。本模型是以下人员的必读之选：
- 需要深入了解週边支架市场的首席行销长 (CMO)，以便为策略规划和投资决策提供资讯。
- 需要了解供应链关键组成部分以进行供应商选择和管理决策的采购主管。
- 需要深入了解市场以识别和评估潜在投资目标的私募股权投资者。
购买理由
本模型可帮助您：
- 透过产品线审查识别关键公司，并制定和设计许可引进和许可输出策略。
- 了解影响和驱动週边支架市场的趋势，并制定业务策略。
- 透过了解关键趋势、创新产品和技术、市场细分以及未来可能影响週边支架市场的公司，实现收入成长。
- 了解竞争格局并分析市场领导者的市场占有率，以製定有效的销售和行销策略。
- 识别具有潜在强大产品组合的新兴公司，并制定有效的应对策略以获得竞争优势。
- 追踪2015年至2036年全球及各国外周支架市场的器材销售情况。
- 识别最具整合、投资和策略联盟机会的市场类别和细分市场，以优化您的销售和行销工作。
Peripheral Vascular Stents Market Size by Segments, Share, Regulatory, Reimbursement, Interventions and Forecast to 2036 is built to visualize quantitative and qualitative market trends within Cardiovascular Devices therapeutic area.
A peripheral vascular stent is an expandable perforated tube that is inserted into a peripheral vessel to prevent blood flow constriction. The aging population, the high prevalence of the disease in developed countries, and the development of new and improved diagnostic modalities have contributed to increased treatment rates using minimally invasive techniques, such as angioplasty and stenting. Minimally invasive techniques used to treat peripheral artery disease (PAD) include balloon angioplasty, stenting, and atherectomy. These interventions have reduced recovery times and the risk of infection and bleeding, and are frequently used in clinical practice. Balloon angioplasty and stenting have replaced invasive artery bypass surgery as the first line of treatment for patients with PAD. These minimally invasive interventions are used to open narrowed and occluded arteries in many different parts of the body, including in the legs, kidneys, as well as carotid arteries. Peripheral stenting involves inserting a stent into the blocked peripheral artery to widen it and allow for normal blood flow through the vessel. Problems associated with balloon angioplasty, such as elastic recoil and neointimal hyperplasia, make stenting the preferable option.
Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with intervention volumes. The interactive excel deliverable covers value, volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.
Key Inclusions of the market model are -
Currently marketed Peripheral Vascular Stents market and evolving competitive landscape -
- Insightful review of the key industry trends.
- Annualized total Peripheral Vascular Stents market revenue by segment and market outlooks from 2015-2036.
- Granular data on total interventions, units, average selling prices and market values by segment.
Global, Regional and Country level market specific insights -
- Qualitative market specific information is available with global trends further broken down into regional trends. In addition GlobalData analysts provide unique country specific insights on the market.
- SWOT analysis for Peripheral Vascular Stents market.
- Competitive dynamics insights and trends provided Peripheral Vascular Stents market.
Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.
- Country specific overview of the healthcare system.
- Country specific reimbursement policies.
- Country specific medtech regulatory landscape.
Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.
Companies covered: W.L. Gore & Associates Inc ,Boston Scientific Corp, CR Bard Inc ,Wilson-Cook Medical Inc ,Abbott Laboratories ,Medtronic Plc, Getinge AB,Cordis Corp,Terumo Corp,Biotronik SE & Co KG,Kyoto Medical Planning Co Ltd
Others.
Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.
Scope
This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -
- CMO executives who must have deep understanding of the Peripheral Vascular Stents marketplace to make strategic planning and investment decisions.
- Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
- Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.
Reasons to Buy
The model will enable you to -
- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products, by identifying key companies.
- Develop business strategies by understanding the trends shaping and driving Peripheral Vascular Stents market.
- Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Peripheral Vascular Stents market in the future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
- Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
- Track device sales in the global and country-specific Peripheral Vascular Stents market from 2015-2036.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
